Development and Validation of a New RP-HPLC Method for the Simultaneous Estimation of Moexipril and Hydrochlorothiazide acid in Pharmaceutical Dosage form as Per ICH guidlines
DOI:
https://doi.org/10.30904/Keywords:
Moexipril, Hydrochlorothiazide, Hypersil C18 column, validation, reliability, RP-HPLC, ICH guidelinesAbstract
This research work verified a HPLC technique for the concurrent identification of Moexipril & Hydrochlorothiazide in formulations. The technique demonstrated high specificity, with a resolution greater than 2 & % assay results of 101% for Moexipril &98.9% for Hydrochlorothiazide. Linearity was confirmed over the range of 20 to 100 µg per ml, with R² of 0.9999 & 0.9989, respectively. Precision was verified with %RSD values of 0.2% & 1.4%, & accuracy was supported by recovery studies yielding mean recoveries of 98.33% & 99.4%. Degradation studies indicated stability under various stress conditions, with minimal degradation (≤ 2.72%). Overall, the technique is robust & suitable for regular analysis in QC laboratories.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Author

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.